MXPA05002942A - Forma de dosificacion oral de liberacion modificada. - Google Patents

Forma de dosificacion oral de liberacion modificada.

Info

Publication number
MXPA05002942A
MXPA05002942A MXPA05002942A MXPA05002942A MXPA05002942A MX PA05002942 A MXPA05002942 A MX PA05002942A MX PA05002942 A MXPA05002942 A MX PA05002942A MX PA05002942 A MXPA05002942 A MX PA05002942A MX PA05002942 A MXPA05002942 A MX PA05002942A
Authority
MX
Mexico
Prior art keywords
oral dosage
dosage form
modified release
release oral
nicotine
Prior art date
Application number
MXPA05002942A
Other languages
English (en)
Spanish (es)
Inventor
Stuart J Platcow
Original Assignee
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp
Publication of MXPA05002942A publication Critical patent/MXPA05002942A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/34—Tobacco-abuse

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Biophysics (AREA)
  • Addiction (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Psychiatry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
MXPA05002942A 2002-09-16 2003-09-16 Forma de dosificacion oral de liberacion modificada. MXPA05002942A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/244,782 US20040052851A1 (en) 2002-09-16 2002-09-16 Modified release oral dosage form
PCT/US2003/029277 WO2004024124A1 (en) 2002-09-16 2003-09-16 Modified release oral dosage form

Publications (1)

Publication Number Publication Date
MXPA05002942A true MXPA05002942A (es) 2006-01-24

Family

ID=31991964

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA05002942A MXPA05002942A (es) 2002-09-16 2003-09-16 Forma de dosificacion oral de liberacion modificada.

Country Status (10)

Country Link
US (2) US20040052851A1 (https=)
EP (1) EP1553925A4 (https=)
JP (1) JP2006503046A (https=)
CN (1) CN1694686A (https=)
AU (1) AU2003267268B2 (https=)
BR (1) BR0314271A (https=)
CA (1) CA2498930A1 (https=)
MX (1) MXPA05002942A (https=)
NZ (1) NZ539445A (https=)
WO (1) WO2004024124A1 (https=)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030159702A1 (en) * 2002-01-21 2003-08-28 Lindell Katarina E.A. Formulation and use manufacture thereof
CN1761458A (zh) * 2003-05-02 2006-04-19 沃尼尔·朗伯有限责任公司 用于向咽喉递送药物活性剂的糖果产品
GB0320854D0 (en) 2003-09-05 2003-10-08 Arrow No 7 Ltd Buccal drug delivery
WO2006000233A1 (en) * 2004-06-29 2006-01-05 Fertin Pharma A/S Tobacco alkaloid containing chewing gum
US8252321B2 (en) 2004-09-13 2012-08-28 Chrono Therapeutics, Inc. Biosynchronous transdermal drug delivery for longevity, anti-aging, fatigue management, obesity, weight loss, weight management, delivery of nutraceuticals, and the treatment of hyperglycemia, alzheimer's disease, sleep disorders, parkinson's disease, aids, epilepsy, attention deficit disorder, nicotine addiction, cancer, headache and pain control, asthma, angina, hypertension, depression, cold, flu and the like
JP5254616B2 (ja) 2004-09-13 2013-08-07 クロノ セラピューティクス、インコーポレイテッド 生物学的同調性（ｂｉｏｓｙｎｃｈｒｏｎｏｕｓ）経皮的薬物送達
US20070269492A1 (en) * 2006-05-16 2007-11-22 Per Steen New product and use and manufacture thereof
US20070269386A1 (en) * 2006-05-16 2007-11-22 Per Steen New product and use and manufacture thereof
EP2322168A1 (en) * 2007-04-02 2011-05-18 Parkinson's Institute Methods and Compositions for Reduction of Side Effects of Therapeutic Treatments
BRPI0821608A2 (pt) * 2007-12-11 2015-09-29 Novartis Ag filmes de multizona
AR071420A1 (es) * 2008-05-01 2010-06-16 Smithkline Beecham Corp Composicion de pastilla para chupar oral que comprende un principio activo de nicotina y procedimiento para fabricarla
US9700525B2 (en) 2008-08-20 2017-07-11 Board Of Supervisors Of Louisiana State University And Agricultural & Mechanical College Continuous local slow-release of therapeutics for head and neck problems and upper aerodigestive disorders
US20100055050A1 (en) * 2008-08-30 2010-03-04 Kathleen Moore Nicotine chewing gum on a stick
US20130017259A1 (en) 2011-07-06 2013-01-17 The Parkinson's Institute Compositions and Methods for Treatment of Symptoms in Parkinson's Disease Patients
US20130078307A1 (en) 2011-09-22 2013-03-28 Niconovum Usa, Inc. Nicotine-containing pharmaceutical composition
US9474303B2 (en) 2011-09-22 2016-10-25 R.J. Reynolds Tobacco Company Translucent smokeless tobacco product
US9629392B2 (en) 2011-09-22 2017-04-25 R.J. Reynolds Tobacco Company Translucent smokeless tobacco product
US9084439B2 (en) 2011-09-22 2015-07-21 R.J. Reynolds Tobacco Company Translucent smokeless tobacco product
US9907748B2 (en) 2011-10-21 2018-03-06 Niconovum Usa, Inc. Excipients for nicotine-containing therapeutic compositions
US9763928B2 (en) * 2012-02-10 2017-09-19 Niconovum Usa, Inc. Multi-layer nicotine-containing pharmaceutical composition
US9044035B2 (en) 2012-04-17 2015-06-02 R.J. Reynolds Tobacco Company Remelted ingestible products
WO2014159673A2 (en) * 2013-03-14 2014-10-02 Altria Client Services Inc. Soft oral product
WO2015068058A1 (en) * 2013-11-06 2015-05-14 Rk Technology & Investments Pte. Ltd. Tobacco free 'niconuts'and the process thereof
US9375033B2 (en) 2014-02-14 2016-06-28 R.J. Reynolds Tobacco Company Tobacco-containing gel composition
JP2018511355A (ja) 2015-01-28 2018-04-26 クロノ セラピューティクス インコーポレイテッドＣｈｒｏｎｏ Ｔｈｅｒａｐｅｕｔｉｃｓ Ｉｎｃ． 薬剤送達方法及びシステム
AU2016228779A1 (en) 2015-03-12 2017-09-07 Chrono Therapeutics Inc. Craving input and support system
EP3565617A1 (en) 2017-01-06 2019-11-13 Chrono Therapeutics Inc. Transdermal drug delivery devices and methods
EP3801732A4 (en) 2018-05-29 2022-04-27 Morningside Venture Investments Limited METHODS AND SYSTEMS FOR DRUG DELIVERY
US12397141B2 (en) 2018-11-16 2025-08-26 Morningside Venture Investments Limited Thermally regulated transdermal drug delivery system
CN114609300A (zh) * 2022-04-07 2022-06-10 国家烟草质量监督检验中心 一种基于动物模型评价薄荷醇添加对口含烟烟碱代谢影响的方法

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2049417B (en) * 1979-05-29 1983-06-15 Mitra A K Extended release antiacid lozenges
IT1191674B (it) * 1986-03-07 1988-03-23 Eurand Spa Formulazioni per la preparazione di farmaci a rilascio prolungato adatte alla somministrazione per via orale
US4814164A (en) * 1986-03-10 1989-03-21 Colgate-Palmolive Company Solid antitartar mouth deodorant composition
US5525351A (en) * 1989-11-07 1996-06-11 Dam; Anders Nicotine containing stimulant unit
US5048544A (en) * 1990-08-10 1991-09-17 Robert Mascarelli Cigarette substitute
US5167964A (en) * 1992-02-14 1992-12-01 Warner-Lambert Company Semi-enteric drug delivery systems and methods for preparing same
US5549906A (en) * 1993-07-26 1996-08-27 Pharmacia Ab Nicotine lozenge and therapeutic method for smoking cessation
US5362496A (en) * 1993-08-04 1994-11-08 Pharmetrix Corporation Method and therapeutic system for smoking cessation
AU4835693A (en) * 1993-08-13 1995-03-14 Rijksuniversiteit Te Groningen Pharmaceutical composition comprising phosphatase or a derivative thereof
PL171939B1 (pl) * 1993-08-16 1997-07-31 Urzadzen Mechanicznych Kamax S Sprzeg, zwlaszcza do pojazdów szynowych PL
US6082368A (en) * 1995-05-08 2000-07-04 Brown; Graham H. Nicotine candy cigarette
DE19606968C2 (de) * 1996-02-24 1998-07-09 Suedzucker Ag Verwendung von 1,1-GPS in Hartkaramellen
PT906089E (pt) * 1996-05-13 2004-01-30 Novartis Consumer Health Sa Sistema de administracao bucal
DE19639342C2 (de) * 1996-09-25 1998-07-16 Suedzucker Ag Kaugummi, enthaltend ein Süßungsmittel
US6270804B1 (en) * 1998-04-03 2001-08-07 Biovail Technologies Ltd. Sachet formulations
DE19815327A1 (de) * 1998-04-06 1999-10-07 Soldan Holding & Bonbonspezial Verfahren zur Herstellung von Kau-Pastillen mit Wirkstoff
DE19818842C1 (de) * 1998-04-28 2000-01-05 Suedzucker Ag Erkältungsmittel
US6322806B1 (en) * 1999-04-06 2001-11-27 Wm. Wrigley Jr. Company Over-coated chewing gum formulations including tableted center
DE20102817U1 (de) * 2000-02-23 2001-06-07 Bolder Arzneimittel GmbH, 50968 Köln Lutsch- und Kaupastillen mit Cyclodextrin
JP2004520389A (ja) * 2001-02-08 2004-07-08 ファルマシア・コーポレーション 性的不全の治療のための早期効果発現薬剤
FR2823974B1 (fr) * 2001-04-25 2004-10-15 Pf Medicament Pastille medicamenteuse a liberation lente du principe actif
US7914811B2 (en) * 2001-06-29 2011-03-29 Mcneil-Ppc, Inc. Brittle-coating, soft core dosage form

Also Published As

Publication number Publication date
AU2003267268B2 (en) 2007-03-15
BR0314271A (pt) 2005-07-05
CN1694686A (zh) 2005-11-09
AU2003267268A1 (en) 2004-04-30
EP1553925A1 (en) 2005-07-20
NZ539445A (en) 2007-03-30
US20040052851A1 (en) 2004-03-18
WO2004024124A1 (en) 2004-03-25
US20040076665A1 (en) 2004-04-22
EP1553925A4 (en) 2012-09-05
JP2006503046A (ja) 2006-01-26
CA2498930A1 (en) 2004-03-25

Similar Documents

Publication Publication Date Title
MXPA05002942A (es) Forma de dosificacion oral de liberacion modificada.
MXPA03008762A (es) Forma de dosificacion oral que contiene nicotina.
PL370292A1 (en) Formulations for oral administration of active compounds
TW200510375A (en) New compounds
MXPA03010134A (es) Derivados de ciclohexan-1-4-diamina sustituidos.
MXPA04004173A (es) Formas orales de liberacion controlada utiles para la reduccion o prevencion de la ansiedad hacia la nicotina.
DE60205870D1 (de) Orale pharmazeutische zusammensetzung aus cefpodoxim-proxetil
MY144659A (en) 2-hydroxy-3-heteroarylindole derivatives as gsk3 inhibitors
MXPA02002249A (es) Composiciones farmaceuticas agradables al paladar para animales de compania.
MXPA03000710A (es) Ciclopentanoindoles, composiciones que contienen estos compuestos y metodos de tratamiento.
MXPA03004832A (es) Compuestos y sus usos.
UA84266C2 (uk) Дозована лікарська форма у вигляді таблетки або пелети для перорального введення, яка містить інгібітор pde 4 та полівінілпіролідон, способи її одержання та застосування
TW200510325A (en) 2-acylamino-4-phenylthiazole derivatives, preparation thereof and therapeutic application thereof
TW200621737A (en) 2-carbamide-4-phenylthiazole derivatives, preparation thereof and therapeutic use thereof
EA200501697A1 (ru) Дозируемая форма, содержащая пантопразол в качестве активного ингредиента
SI1596841T1 (sl) Terapevtski sistem amoksicilina in klavulanske kisline
MXPA03008801A (es) Aril oxima-piperazinas utiles como antagonistas de ccr5.
SE0200657D0 (sv) Novel Formulation
TW200503785A (en) Dosage form containing (S)-pantoprazole as active ingredient
GB0212410D0 (en) Organic compounds
MY142076A (en) Emulsifying systems containing azetidine derivatives
MXPA04004090A (es) Compuestos substituidos de 1h-quinolin-2-ona.
UA87291C2 (ru) Пероральное пленкообразное лекарственное средство дезоксипеганина и способ его применения
SG144141A1 (en) Semi-solid systems containing azetidine derivatives
MXPA03003466A (es) Derivados de piranosido.